JRI ORTHOPAEDICS LIMITED
Get an alert when JRI ORTHOPAEDICS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-09-23 (in 4mo)
Last made up 2025-09-09
Watchouts
None on the register
Cash
£3M
+17.7% vs 2023
Net assets
£15M
+5.4% vs 2023
Employees
115
+2.7% vs 2023
Profit before tax
£916K
+108.7% vs 2023
Name history
Renamed 1 time since incorporation
- JRI ORTHOPAEDICS LIMITED 2011-10-21 → present
- JOINT REPLACEMENT INSTRUMENTATION LIMITED 1970-04-06 → 2011-10-21
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £17,341,000 | £17,781,000 | |
| Operating profit | £463,000 | £898,000 | |
| Profit before tax | £439,000 | £916,000 | |
| Net profit | £371,000 | £764,000 | |
| Cash | £2,390,000 | £2,814,000 | |
| Total assets less current liabilities | £14,298,000 | £15,203,000 | |
| Net assets | £14,155,000 | £14,919,000 | |
| Equity | £14,155,000 | £14,919,000 | |
| Average employees | 112 | 115 | |
| Wages | £4,781,000 | £4,844,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 2.7% | 5.1% | |
| Net margin | 2.1% | 4.3% | |
| Return on capital employed | 3.2% | 5.9% | |
| Current ratio | 5.29x | 6.06x | |
| Interest cover | 10.07x | 49.89x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102 §1A
- Reporting scope
- Standalone (parent only)
- Auditor
- KPMG LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors have prepared the financial statements on the going concern basis as they do not intend to liquidate the company or to cease in its operations, and as they have concluded that the company's financial position means that this is realistic. They have also considered that there are no material uncertainties that could have cast significant doubt over its ability to continue as a going concern for at least a year from the date of approval of the financial statements (the "going concern period").”
Group structure
- JRI ORTHOPAEDICS LIMITED · parent
- Joint Replacement Instrumentation Limited 100%
- JRI (Manufacturing) Limited 100%
- Orthorais Limited 100%
- Sheffield Medical Products Limited 100%
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 19 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CHUNG, Teck Kiong | Director | 2019-10-23 | Sep 1980 | British |
| GUOWEI, Wang David | Director | 2018-04-10 | Sep 1961 | American |
| XIAOHONG, Zhao | Director | 2018-04-10 | Oct 1977 | Chinese |
| ZHIJIANG, Li | Director | 2018-04-10 | Jan 1968 | Chinese |
Show 19 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| COAKLEY, Ciaran Francis | Secretary | 2003-09-02 | 2006-03-31 |
| FURLONG, Eileen Mary | Secretary | — | 2003-08-25 |
| CARGIL MANAGEMENT SERVICES LIMITED | Corporate Secretary | 2006-03-31 | 2014-11-07 |
| AGASS, Jeremy Edward | Director | 2015-01-01 | 2025-05-31 |
| AYRES, Stephen George | Director | 2015-02-02 | 2019-08-16 |
| COAKLEY, Ciaran Francis | Director | 2003-09-02 | 2009-03-31 |
| COLLINS, Frank Thomas, Mr. | Director | 2016-04-01 | 2018-04-10 |
| EDGE, Anthony John | Director | 2016-09-19 | 2018-04-10 |
| FATHERS, Dean Harry | Director | 2010-04-05 | 2016-04-05 |
| FIFIELD, Clifford John | Director | 2009-01-22 | 2014-12-05 |
| FURLONG, Eileen Mary | Director | — | 2003-08-25 |
| FURLONG, Ronald John | Director | — | 2002-08-12 |
| HARKNESS, Sarah Helen | Director | 2011-03-01 | 2017-08-31 |
| HOUBEN, Henry Emile, Dr | Director | 2004-09-30 | 2009-12-19 |
| JACKSON, Keith Robert, Professor | Director | 2003-04-01 | 2017-02-20 |
| JONES, Brian Philip | Director | 2002-08-21 | 2016-03-31 |
| POOLE, Geoffrey Donovan | Director | — | 2004-09-30 |
| WALKER, Kenneth Alexander | Director | — | 2010-03-31 |
| WIDDALL, Howard Mark | Director | 2009-01-22 | 2016-03-31 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Ak Medical Overseas Limited | Corporate entity | Shares 75–100% | 2020-04-30 | Ceased 2020-04-30 |
| Mr Zhijiang Li | Individual | Shares 25–50%, Voting 25–50% | 2018-04-10 | Ceased 2022-07-25 |
| Mr Zhijiang Li | Individual | Shares 50–75%, Voting 50–75% | 2018-04-10 | Ceased 2020-04-30 |
| Orthopaedic Research Uk | Corporate entity | Shares 75–100% | 2016-04-06 | Ceased 2018-04-10 |
Filing timeline
Last 20 of 166 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-12-29 | AA | accounts | Accounts with accounts type full | |
| 2025-09-30 | TM01 | officers | Termination director company with name termination date | |
| 2025-09-23 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-09-17 | AA | accounts | Accounts with accounts type full | |
| 2024-09-09 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-10-18 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-05-16 | AA | accounts | Accounts with accounts type full | |
| 2022-09-27 | AA | accounts | Accounts with accounts type full | |
| 2022-09-22 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-07-25 | PSC08 | persons-with-significant-control | Notification of a person with significant control statement | |
| 2022-07-25 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2022-07-18 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2022-07-18 | PSC01 | persons-with-significant-control | Notification of a person with significant control | |
| 2021-10-20 | AA | accounts | Accounts with accounts type full | |
| 2021-09-14 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2020-12-24 | AA | accounts | Accounts with accounts type full | |
| 2020-10-19 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2020-08-19 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2020-08-19 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2019-11-13 | AP01 | officers | Appoint person director company with name date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+2.5%
£17,341,000 £17,781,000
-
Cash
+17.7%
£2,390,000 £2,814,000
-
Net assets
+5.4%
£14,155,000 £14,919,000
-
Employees
+2.7%
112 115
-
Operating profit
+94%
£463,000 £898,000
-
Profit before tax
+108.7%
£439,000 £916,000
-
Wages
+1.3%
£4,781,000 £4,844,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers